Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_assertion type Assertion NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_head.
- NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_assertion description "[In approximately 70% of human extraskeletal myxoid chondrosarcoma (EMC) tumors, a t(9;22) chromosome translocation gives rise to a fusion protein, named EWS/NOR1, containing the amino-terminal domain of EWS fused to the complete amino acid sequence of the nuclear receptor NOR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_provenance.
- NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_assertion evidence source_evidence_literature NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_provenance.
- NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_assertion SIO_000772 16112421 NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_provenance.
- NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_assertion wasDerivedFrom befree-20150227 NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_provenance.
- NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_assertion wasGeneratedBy ECO_0000203 NP778509.RATbDyXvVD9-2VaXocgRqfgr3DhFrqA1c0M0iqdowAxoc130_provenance.